Table 1. Demographics of renal allograft recipients (immunosuppressed) and immunocompetent patients (median, minimum, and maximum; number and percentage).
| Renal transplant recipients (N=33) | Immunocompetent controls (N=54) | |
|---|---|---|
| Age (years) | 67 (44–78) | 71 (43–87) |
| Gender (male, %) | 24 (72.7) | 37 (68.5) |
| Time since transplantation (years) | 10.5 (1–38) | — |
| Duration of haemodialysis (years) | 3 (0–15) | — |
| Renal disease (number, %) | — | |
| Diabetes | 3 (9.1) | |
| Hypertension | 3 (9.1) | |
| Glomerulonephritis | 16 (48.5) | |
| ADPKD | 4 (12.1) | |
| Others | 7 (21.2) | |
| Transplantation | — | |
| First (number, %) | 26 (78.8) | |
| Second (number, %) | 6 (18.2) | |
| Third (number, %) | 1 (3.0) | |
| Renal allograft function | ||
| Creatinine (mg dl−1) | 1.18 (0.63–2.29) | |
| Immunosuppression at time of transplantation/ at time of first non-melanoma skin lesion | ||
| Ciclosporin A+Azathioprin+Steroids | 12/4 | |
| Azathioprin+Steroids | 5/1 | |
| Ciclosporin A+Steroids | 5/16 | |
| Ciclosporin A+MMF+Steroids | 9/9 | |
| Tacrolimus+MMF+Steroids | 2/3 | |
Abbreviations: ADPKD=autosomal dominant polycystic kidney disease; MMF=mycophenolate mofetil.